However, a major shift occurred in November 2025 when the Trump administration negotiated MFN pricing deals with Novo Nordisk and Eli Lilly, reducing Medicare/Medicaid prices for Ozempic, Wegovy, Zepbound, and Mounjaro to approximately $245/month , with Medicare beneficiary co-pays of $50/month ( [17] ) ( [22] )
What changed is the temporary Bridge program, which, as of July 1, 2026, gives eligible people with Medicare Part D coverage Wegovy injections and pills, Zepbound KwikPen, and Foundayo for $50 a month
The NIH (National Institutes of Health) says that 10 to 35% of your daily calories should come from protein to promote fullness and control appetite
However, always check with your healthcare provider for potential interactions before taking any other medicines
Vantalite 250 mg tablets are formulated for regular adult use as part of a balanced diet and healthy lifestyle